Mylan enters settlement and license deal with Roche over Xeloda - Pharmaceutical and Biotechnology News - Pharma Letter

Mylan enters settlement and license deal with Roche over Xeloda - Pharmaceutical and Biotechnology News - Pharma Letter | Patexia